Elevance Health Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Elevance Health Stock Forecast and Price Target
Elevance Health's stock price reaches the average target of $585.00 by 2025 as expected recently by notable experts, there would be a potential upside of approximately 11.39% from the last closing price in April, 2024. This possible increase is based on a high estimate of $630.00 and a low estimate of $520.00. If you are not interested in ELV stock, you may be interested in its competitors.
11.39% Upside
Elevance Health Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Elevance Health's Price has decreased from $338.10 to $0.00 – a 100.00% drop. The next year looks promising for Elevance Health, with analysts predicting Fair Value of $553.02 – an increase of 100.00%. Over the next seven years, experts anticipate that Elevance Health's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRK.A Stock Forecast | Berkshire Hathaway Inc | Outperform |
7
|
$604.14k | Buy/Sell | $621.67k | 6.76% |
| WMT Stock Forecast | Walmart Inc | Outperform |
15
|
$59.26 | Buy/Sell | $179.15 | 11.37% |
| UNH Stock Forecast | UnitedHealth Group | Buy |
16
|
$493.18 | Buy/Sell | $595.09 | 13.95% |
| ALV Stock Forecast | Allianz | Outperform |
10
|
262.00€ | Buy/Sell | 267.63€ | 5.53% |
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$348.78 | Buy/Sell | $354.48 | 10.38% |
Elevance Health Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Elevance Health's Revenue has grown, increasing from $121.87B to $171.34B – a growth of 40.59%. The next year looks promising for Elevance Health, with analysts predicting Revenue of $173.96B – an increase of 1.53%. Over the next seven years, experts anticipate that Elevance Health's Revenue will grow at a rate of 24.83%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2628 Stock Forecast | China Life Insurance Company | Outperform |
10
|
HK$9.06 | Buy/Sell | HK$13.60 | 47.02% |
| CS Stock Forecast | AXA | Outperform |
10
|
33.82€ | Buy/Sell | 32.17€ | 9.40% |
| MUV2 Stock Forecast | Münchener Rückversicherungs-... | Outperform |
9
|
413.00€ | Buy/Sell | 394.57€ | 10.77% |
.jpg)
Elevance Health Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Elevance Health's Dividend per Share has grown by 55.79%, from $3.80 to $5.92. 6 analysts predict Elevance Health's Dividend per Share will decrease by 9.97% in the next year, reaching $5.33. Over the next seven years, experts predict that Dividend per Share will grow by 94.09%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AIG Stock Forecast | American International Group | Outperform |
8
|
$72.99 | Buy/Sell | $76.11 | 13.03% |
| AFL Stock Forecast | Aflac | Hold |
7
|
$80.98 | Buy/Sell | $82.50 | 3.73% |
| HUM Stock Forecast | Humana | Outperform |
14
|
$324.83 | Buy/Sell | $426.74 | 19.45% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CNC Stock Forecast | Centene | Outperform |
11
|
$73.75 | Buy/Sell | $88.33 | 22.03% |
| G Stock Forecast | Assicurazioni Generali S.p.A. | Hold |
18
|
22.53€ | Buy/Sell | 20.93€ | 2.89% |
| L Stock Forecast | Loblaw Companies | Outperform |
18
|
C$148.23 | Buy/Sell | C$103.00 | 4.23% |
Elevance Health EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Elevance Health's EBITDA has grown by 21.63%, rising from $9.00B to $10.95B. For next year, analysts predict EBITDA of $13.39B, which would mean an increase of 22.33%. Over the next seven years, experts predict that Elevance Health's EBITDA will grow at a rate of 62.07%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$106.00 | Buy/Sell | $108.07 | 8.96% |
| MOH Stock Forecast | Molina Healthcare | Outperform |
16
|
$360.94 | Buy/Sell | $393.38 | 15.91% |
| 8725 Stock Forecast | MS&AD Insurance Group Holdings | Outperform |
14
|
¥7.46k | Buy/Sell | ¥5.83k | -20.94% |
Elevance Health EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Elevance Health's EBIT has grown by 19.72%, rising from $8.26B to $9.89B. For next year, analysts predict EBIT of $12.26B, which would mean an increase of 23.97%. Over the next seven years, experts predict that Elevance Health's EBIT will grow at a rate of 44.94%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AV. Stock Forecast | Aviva | Outperform |
16
|
£4.57 | Buy/Sell | £4.81 | 11.60% |
| UHS Stock Forecast | Universal Health Services | Outperform |
6
|
$153.65 | Buy/Sell | $162.38 | 21.71% |
| THC Stock Forecast | Tenet Healthcare | Outperform |
15
|
$91.08 | Buy/Sell | $86.63 | 24.07% |
Elevance Health EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Elevance Health's EPS has decreased from $22.48 to $0.00 – a 100.00% drop. The next year looks promising for Elevance Health, with analysts predicting EPS of $36.77 – an increase of 100.00%. Over the next seven years, experts anticipate that Elevance Health's EPS will grow at a rate of 100.00%.
.jpg)